NO970284D0 - Method of treating opportunistic infections with azaspirans - Google Patents

Method of treating opportunistic infections with azaspirans

Info

Publication number
NO970284D0
NO970284D0 NO970284A NO970284A NO970284D0 NO 970284 D0 NO970284 D0 NO 970284D0 NO 970284 A NO970284 A NO 970284A NO 970284 A NO970284 A NO 970284A NO 970284 D0 NO970284 D0 NO 970284D0
Authority
NO
Norway
Prior art keywords
azaspirans
opportunistic infections
treating opportunistic
treating
infections
Prior art date
Application number
NO970284A
Other languages
Norwegian (no)
Other versions
NO970284L (en
NO310096B1 (en
Inventor
Alison Mary Badger
Peter John Bugelski
Danuta J Herzyk
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO970284D0 publication Critical patent/NO970284D0/en
Publication of NO970284L publication Critical patent/NO970284L/en
Publication of NO310096B1 publication Critical patent/NO310096B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
NO19970284A 1994-07-23 1997-01-22 Use of azaspirans NO310096B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9414902A GB9414902D0 (en) 1994-07-23 1994-07-23 Methods
PCT/US1995/008915 WO1996003126A1 (en) 1994-07-23 1995-07-14 Method of treating opportunistic infections with azaspiranes

Publications (3)

Publication Number Publication Date
NO970284D0 true NO970284D0 (en) 1997-01-22
NO970284L NO970284L (en) 1997-03-19
NO310096B1 NO310096B1 (en) 2001-05-21

Family

ID=10758802

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19970284A NO310096B1 (en) 1994-07-23 1997-01-22 Use of azaspirans

Country Status (15)

Country Link
EP (1) EP0804201A4 (en)
JP (1) JPH10503202A (en)
KR (1) KR970704446A (en)
CN (1) CN1157564A (en)
AU (1) AU684384B2 (en)
BR (1) BR9508332A (en)
CA (1) CA2195778A1 (en)
CZ (1) CZ286482B6 (en)
GB (1) GB9414902D0 (en)
HU (1) HUT77379A (en)
MX (1) MX9700626A (en)
NO (1) NO310096B1 (en)
NZ (1) NZ290974A (en)
WO (1) WO1996003126A1 (en)
ZA (1) ZA956098B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (en) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N, n-diethyl-8,8-dipropyl-2-azaspiro (4,5) decane-2-propan amine dimaleate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963557A (en) * 1987-09-28 1990-10-16 Smithkline Beecham Corporation Immunomodulatory azaspiranes
ZA921120B (en) * 1991-02-19 1993-01-27 Smithkline Beecham Corp Cytokine inhibitors
PT100566B (en) * 1991-06-07 1999-06-30 Smithkline Beecham Corp IMMUNOMODULATOR AZASPIRANES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION AND USE

Also Published As

Publication number Publication date
MX9700626A (en) 1997-05-31
JPH10503202A (en) 1998-03-24
KR970704446A (en) 1997-09-06
CA2195778A1 (en) 1996-02-08
HU9700201D0 (en) 1997-04-28
NO970284L (en) 1997-03-19
AU684384B2 (en) 1997-12-11
NZ290974A (en) 1999-08-30
BR9508332A (en) 1997-11-04
WO1996003126A1 (en) 1996-02-08
CZ20997A3 (en) 1997-10-15
HUT77379A (en) 1998-04-28
EP0804201A4 (en) 2000-04-26
EP0804201A1 (en) 1997-11-05
ZA956098B (en) 1996-05-23
CZ286482B6 (en) 2000-04-12
CN1157564A (en) 1997-08-20
NO310096B1 (en) 2001-05-21
AU3190995A (en) 1996-02-22
GB9414902D0 (en) 1994-09-14

Similar Documents

Publication Publication Date Title
NO985591D0 (en) Method of removing absorbent articles
NO20002172D0 (en) Method of treating hypercholesterolemia with unsubstituted polydiallylamine
NO991955L (en) Process for the treatment of hydrocarbons
NO983284D0 (en) Anticoagulants suitable for the treatment of thrombosis
NO971468D0 (en) Method of treating nutritious water
BR9509904A (en) Process for the purification and isolation of 2-deoxy-2,2-difluor-nucleosides
BR9506606A (en) Method of treating estrogen-dependent ovarian conditions
NO20010117L (en) Method of treating insomnia
NO963322D0 (en) Procedure for the treatment of abstinence in substance abuse
BR9400475A (en) Preparation process of modified zeolite and modified zeolite
NO992854L (en) Method of treating cellulose molding
NO953443D0 (en) Process for the treatment of solid waste
BR9502092A (en) Set of locks
NO972402D0 (en) Process for the preparation of carriers
NO964918D0 (en) Process of drying
PT719499E (en) ANTI-GERMINATIVE TREATMENT PROCESS OF TUBERCULOS OR BOLBOS
DE69717846T2 (en) TREATMENT METHOD OF LACTATAS
NO984145D0 (en) Method of treating cocoa
NO962940D0 (en) Process of hydroisomerization
IS4285A (en) Method of preventing deposition
NO970284L (en) Method of treating opportunistic infections with azaspirans
MD186B1 (en) Method of treatment of endometritis after cesarean section
NO20006383D0 (en) Process of treatment
NO970118L (en) Compound and method of treating hair loss
BR9507375A (en) Treatment of particulate surfaces

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2003